HEFT Repository

Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation.

Marsh, J C and Pearce, R M and Koh, M B C and Lim, Z and Pagliuca, A and Mufti, G J and Perry, J and Snowden, J A and Vora, A J and Wynn, R T and Russell, N and Gibson, B and Gilleece, M and Milligan, Donald and Veys, P and Samarasinghe, S and McMullin, M and Kirkland, K and Cook, G (2014) Retrospective study of alemtuzumab vs ATG-based conditioning without irradiation for unrelated and matched sibling donor transplants in acquired severe aplastic anemia: a study from the British Society for Blood and Marrow Transplantation. Bone marrow transplantation, 49 (1). pp. 42-8. ISSN 1476-5365. Full Text available via official URL.

Full text not available from this repository.
Official URL: http://www.nature.com/bmt/journal/v49/n1/full/bmt2...

Abstract

This retrospective national study compared the use of alemtuzumab-based conditioning regimens for hematopoietic SCT (HSCT) in acquired severe aplastic anemia with antithymocyte globulin (ATG)-based regimens. One hundred patients received alemtuzumab and 55 ATG-based regimens. A matched sibling donor (MSD) was used in 87 (56%), matched unrelated donor (MUD) in 60 (39%) and other related or mismatched unrelated donor (UD) in 8 (5%) patients. Engraftment failure occurred in 9% of the alemtuzumab group and 11% of the ATG group. Five-year OS was 90% for the alemtuzumab and 79% for the ATG groups, P=0.11. For UD HSCT, OS of patients was better when using alemtuzumab (88%) compared with ATG (57%), P=0.026, although smaller numbers of patients received ATG. Similar outcomes for MSD HSCT using alemtuzumab or ATG were seen (91% vs 85%, respectively, P=0.562). A lower risk of chronic GVHD (cGVHD) was observed in the alemtuzumab group (11% vs 26%, P=0.031). On multivariate analysis, use of BM as stem cell source was associated with better OS and EFS, and less acute and cGVHD; young age was associated with better EFS and lower risk of graft failure. This large study confirms successful avoidance of irradiation in the conditioning regimens for MUD HSCT patients.

Item Type: Article
Additional Information: Full Text available via official URL.
Subjects: QV Pharmacology
WH Haemic and lymphatic systems. Haematology
Divisions: Planned IP Care > Oncology and Clinical Haematology
Related URLs:
Depositing User: Sophie Rollason
Date Deposited: 04 Jul 2014 09:34
Last Modified: 04 Jul 2014 09:34
URI: http://www.repository.heartofengland.nhs.uk/id/eprint/482

Actions (login required)

View Item View Item